Загрузка...
p53 and p16(Ink4a)/p19(Arf) Loss Promotes Different Pancreatic Tumor Types from PyMT-Expressing Progenitor Cells()()
In human studies and mouse models, the contributions of p53 and p16(Ink4a)/p19(Arf) loss are well established in pancreatic ductal adenocarcinoma (PDAC). Although loss of functional p53 pathway and loss of Ink4a/Arf in human pancreatic acinar cell carcinoma (PACC) and pancreatic neuroendocrine tumor...
Сохранить в:
| Опубликовано в: : | Neoplasia |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Neoplasia Press
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5035259/ https://ncbi.nlm.nih.gov/pubmed/27664376 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2016.08.003 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|